Pharmacokinetics of SR-16234 in Postmenopausal Females with Locally Advanced, Locally Recurrent Inoperable, or Progressive Metastatic Breast Cancer.
Phase of Trial: Phase I
Latest Information Update: 05 Nov 2010
At a glance
- Drugs SR 16234 (Primary)
- Indications Advanced breast cancer; Menopause
- Focus Adverse reactions; Pharmacokinetics
- 05 Nov 2010 New trial record.